Armata Pharmaceuticals (ARMP) Operating Expenses: 2013-2018
Historic Operating Expenses for Armata Pharmaceuticals (ARMP) over the last 6 years, with Dec 2018 value amounting to $2.8 million.
- Armata Pharmaceuticals' Operating Expenses rose 17.15% to $2.8 million in Q4 2018 from the same period last year, while for Dec 2018 it was $17.2 million, marking a year-over-year increase of 5.72%. This contributed to the annual value of $47.6 million for FY2024, which is 4.82% up from last year.
- Latest data reveals that Armata Pharmaceuticals reported Operating Expenses of $2.8 million as of Q4 2018, which was up 15.03% from $2.4 million recorded in Q3 2018.
- Armata Pharmaceuticals' Operating Expenses' 5-year high stood at $11.9 million during Q4 2016, with a 5-year trough of $784,000 in Q3 2017.
- Over the past 3 years, Armata Pharmaceuticals' median Operating Expenses value was $3.4 million (recorded in 2016), while the average stood at $5.0 million.
- As far as peak fluctuations go, Armata Pharmaceuticals' Operating Expenses skyrocketed by 287.42% in 2016, and later crashed by 79.93% in 2017.
- Quarterly analysis of 5 years shows Armata Pharmaceuticals' Operating Expenses stood at $2.7 million in 2014, then grew by 13.71% to $3.1 million in 2015, then spiked by 287.42% to $11.9 million in 2016, then crashed by 79.93% to $2.4 million in 2017, then grew by 17.15% to $2.8 million in 2018.
- Its Operating Expenses was $2.8 million in Q4 2018, compared to $2.4 million in Q3 2018 and $9.6 million in Q2 2018.